{"id":"https://openalex.org/W3003185697","doi":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","title":"In Vitro Evaluation of Excipients as Inhibitors of Human Intestinal P\u2010glycoprotein","display_name":"In Vitro Evaluation of Excipients as Inhibitors of Human Intestinal P\u2010glycoprotein","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W3003185697","doi":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","mag":"3003185697"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2019.33.1_supplement.814.3","doi":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036366662","display_name":"Ruchika Bajaj","orcid":"https://orcid.org/0000-0002-9777-0364","observed_orcids":["https://orcid.org/0000-0002-9777-0364"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruchika Bajaj","raw_affiliation_strings":["Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039448346","display_name":"Lisa B Chong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa B Chong","raw_affiliation_strings":["Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076144250","display_name":"Ling Zou","orcid":"https://orcid.org/0000-0002-0128-7950","observed_orcids":["https://orcid.org/0000-0002-0128-7950"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ling Zou","raw_affiliation_strings":["Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013968242","display_name":"Eleftheria Tsakalozou","orcid":"https://orcid.org/0000-0003-1993-8528","observed_orcids":["https://orcid.org/0000-0003-1993-8528"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleftheria Tsakalozou","raw_affiliation_strings":["Center of Drug Evaluation and Research US Food and Drug Administration Silver Spring MD","Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Drug Evaluation and Research US Food and Drug Administration Silver Spring MD","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108715884","display_name":"Zhanglin Ni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhanglin Ni","raw_affiliation_strings":["Center of Drug Evaluation and Research US Food and Drug Administration Silver Spring CA","Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Drug Evaluation and Research US Food and Drug Administration Silver Spring CA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, CA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081414468","display_name":"Kathleen M. Giacomini","orcid":"https://orcid.org/0000-0001-8041-5430","observed_orcids":["https://orcid.org/0000-0001-8041-5430"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen M Giacomini","raw_affiliation_strings":["Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055451852","display_name":"Deanna L. Kroetz","orcid":"https://orcid.org/0000-0001-5997-270X","observed_orcids":["https://orcid.org/0000-0001-5997-270X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deanna L Kroetz","raw_affiliation_strings":["Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering and therapeutic sciences University of California San Francisco San Francisco CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Bioengineering and therapeutic sciences, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.1816,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.56954009,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"33","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9079999923706055},{"id":"https://openalex.org/keywords/intestinal-drug-transporters","display_name":"intestinal drug transporters","score":0.5690000057220459},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.9679999947547913},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibition","display_name":"P-glycoprotein inhibition","score":0.7120000123977661},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9300000071525574},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.6850000023841858},{"id":"https://openalex.org/keywords/food-dyes","display_name":"food dyes","score":0.49900001287460327},{"id":"https://openalex.org/keywords/butylparaben","display_name":"butylparaben","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hek293-cells","display_name":"HEK293 cells","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.8659940958023071},{"id":"https://openalex.org/C2776872141","wikidata":"https://www.wikidata.org/wiki/Q413006","display_name":"Calcein","level":3,"score":0.799723207950592},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7691818475723267},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7337140440940857},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.7113369107246399},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.575203537940979},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5371654033660889},{"id":"https://openalex.org/C193176779","wikidata":"https://www.wikidata.org/wiki/Q5016050","display_name":"Caco-2","level":3,"score":0.4420681297779083},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.38615790009498596},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.35242941975593567},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3186880350112915},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11302253603935242},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.07134205102920532},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.06603661179542542},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2019.33.1_supplement.814.3","doi":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.814.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5099999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2436711697","https://openalex.org/W2184324399","https://openalex.org/W4229457406","https://openalex.org/W2317193739","https://openalex.org/W2129149779","https://openalex.org/W1510465827","https://openalex.org/W2069755270","https://openalex.org/W2365740243","https://openalex.org/W4389166157","https://openalex.org/W2386109104"],"abstract_inverted_index":{"P\u2010glycoprotein":[0],"(P\u2010gp)":[1],"is":[2,35,62,280,288],"one":[3,184],"of":[4,21,28,65,89,112,124,143,189,196,207,216,233,248,268,275],"the":[5,14,33,41,63,213,231,266,272,282],"major":[6],"barriers":[7],"to":[8,13,86,202,264],"oral":[9,273],"bioavailability":[10,274],"and":[11,47,61,183],"contributes":[12],"interindividual":[15],"variability":[16],"observed":[17,126],"in":[18,32,51,96,127,242,298],"intestinal":[19,45,252],"absorption":[20],"P\u2010gp":[22,30,46,90,102,128,250,276],"substrates.":[23,277],"A":[24,68],"well":[25],"characterized":[26],"source":[27],"variable":[29],"function":[31,92],"intestine":[34],"inhibition":[36,88,111,125,135,195,247],"by":[37,93,117],"co\u2010administered":[38],"drugs.":[39],"However,":[40],"potential":[42,158,191,209],"interplay":[43],"between":[44],"pharmaceutical":[48],"excipients":[49,95,118,270],"used":[50,85],"orally":[52],"administered":[53],"drug":[54],"products":[55],"has":[56],"not":[57],"been":[58],"systematically":[59],"studied":[60],"focus":[64],"this":[66,295],"investigation.":[67],"fluorescence":[69],"assay":[70],"using":[71],"calcein":[72,114],"AM":[73,115],"(5":[74],"mM),":[75],"which":[76],"served":[77],"as":[78,121],"a":[79,122],"model":[80],"substrate":[81],"for":[82],"P\u2010gp,":[83],"was":[84,119,137,155],"assess":[87,265],"transport":[91],"130":[94],"HEK293":[97],"cells":[98,130],"stably":[99],"expressing":[100],"human":[101,249],"or":[103,148],"transfected":[104],"with":[105,230,294],"an":[106,140],"empty":[107],"vector":[108],"(control).":[109],"Specific":[110],"P\u2010gp\u2010mediated":[113],"efflux":[116,198],"expressed":[120],"ratio":[123,161],"overexpressing":[129],"over":[131],"control":[132],"cells.":[133],"An":[134],"screen":[136],"performed":[138],"at":[139,149,199,251],"excipient":[141,153,218,253],"concentration":[142],"200":[144],"mM":[145,151],"where":[146,152],"possible,":[147],"50":[150],"solubility":[154],"limiting.":[156],"Six":[157],"inhibitors":[159,192,210],"(inhibition":[160],">1.3)":[162],"were":[163],"identified,":[164],"including":[165],"five":[166],"dyes":[167],"(D&C":[168],"Red":[169],"#6,":[170],"D&C":[171],"Brown#1,":[172],"Naphthol":[173],"blue":[174,177],"black,":[175],"Acid":[176],"9,":[178],"Light":[179],"green":[180,235],"CF":[181,236],"yellowish)":[182],"suspending":[185],"agent":[186],"(Butylparaben).":[187],"None":[188],"these":[190,208,241,269],"achieved":[193],">30%":[194],"calcein\u2010AM":[197],"concentrations":[200,206,254],"up":[201],"300":[203],"mM.":[204],"Intestinal":[205],"estimated":[211],"from":[212,227,257,281],"maximum":[214],"amount":[215],"each":[217],"allowed":[219],"per":[220],"unit":[221],"dose":[222],"(":[223],"http://excipients.ucsf.bkslab.org/":[224],")":[225],"ranged":[226],"0.50\u20132.3":[228],"mM,":[229],"exception":[232],"light":[234],"yellowish":[237],"(214":[238],"mM).":[239],"While":[240],"vitro":[243],"findings":[244],"indicate":[245],"minimal":[246],"typically":[255],"expected":[256],"marketed":[258],"drugs,":[259],"further":[260],"studies":[261],"are":[262],"needed":[263],"impact":[267],"on":[271],"This":[278],"abstract":[279,296],"Experimental":[283],"Biology":[284],"2019":[285],"Meeting.":[286],"There":[287],"no":[289],"full":[290],"text":[291],"article":[292],"associated":[293],"published":[297],"The":[299],"FASEB":[300],"Journal":[301],".":[302]},"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}